Breaking News
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - New model more effective in predicting risk of opioid overdose than traditional models
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
New breakthroughs for muscular dystrophy research

New breakthroughs for muscular dystrophy research

image_pdfDownload PDFimage_print
New breakthroughs for muscular dystrophy research
A C. elegans worm expresses a calcium indicator molecule in its muscles. When muscles contract and calcium is released, this molecule (called GCaMP) binds to it and emits light. This allows scientists to measure how hard the muscles of the animals are working, and how fast calcium is released and cleared from the cell. Credit: Illinois State University

A new study by Illinois State University’s Andrés Vidal-Gadea is breaking ground in the field of muscular dystrophy research.

Published Tuesday in Proceedings of The National Academy of Science of the United States of America, the study lays out the success of Vidal-Gadea’s lab in mirroring symptoms of muscular dystrophy in an animal, the C. elegans worm.

“That had been a big snag in this research field,” said Vidal-Gadea, who noted the worms share two-thirds of the same genes as humans, and build muscles the same way. “No animal gets as sick as we do, so when you try to study this disease and the animal doesn’t get as sick, you cannot make a lot of progress when studying this disease.” The lab managed to grow the worms where the gene was “broken” with muscular dystrophy the same as it is in humans.

The innovative study, which is funded through the National Institutes of Health, also pioneered new methods of studying C. elegans in more natural environments, all with the aim of seeing if exercise produces long-term beneficial effects for muscular dystrophy patients.

“Rather than just grown on top of a petri plate, as is tradition, we could watch them burrow,” said Vidal-Gadea, an assistant professor of molecular neuroethology, who employs the worms in a variety of neurological studies. The new method brought out the phenotype of the disease—or led to the worms displaying the illness.

Students in the lab altered the exercise regime for worms to mimic different activities. Some C. elegans simply sat near food. Others swam to mirror high-frequency/low impact exercise such as jogging. Still others burrowed through gelatin to give the same effect as weight-lifting. Over time, worms that exercised built up muscles at different levels, but saw no change in the length of life or in the course of disease.

“It’s unfortunate, but our interpretation is that the exercise tested does not impact the course of the disease,” said Vidal-Gadea.

The work touches close to home for Vidal-Gadea, who worked with patients with muscular dystrophy when he was an undergraduate student studying at the University of Victoria in British Columbia, Canada. At times, clients who would try different methods of exercise could end up worse off than when they started. “That was brutal to see. They were trading their health for a chance to get better, but there is nothing in the literature that is conclusive about what helps,” he said.

The failure is not in the exercise itself, but how the disease operates, noted Vidal-Gadea. He compared muscles to the engine of a car that provide force. “You can build up the engine and gather more force,” he said. “But the problem isn’t the engine, it’s in how the force is transmitted. So just building muscles alone is like trying to put a Formula 1 engine into a little Volkswagen bug when the transmission is broken. You might just tear your car apart. Now, if you only look at some of the parameters like maximal RPMs of the engine, you may be led to believe that the treatment helped.”

The three-year study will also help scientists better understand the chain of events when humans develop muscular dystrophy, and the symptoms that arise. “We know that when people get muscular dystrophy, the gene is broken and muscles die,” said Vidal-Gadea, “but there are a lot of things that happen in between that we don’t know.” He added that piecing together the chain will give scientists a view into what damage is caused by the disease and what is sparked by the muscles trying to fight back.

One step along the chain Vidal-Gadea’s team examined was the amount of calcium released in the muscles of those battling Duchenne muscular dystrophy. “There is a build-up of calcium that is released when the muscles contract,” said Vidal-Gadea. “For those who have muscular dystrophy, the amount of calcium released can be notably higher.” The study examined the changes in calcium as the worms moved. “We can begin to see where and when the calcium in the muscles becomes dysregulated. This gives us potential targets to go after to make improvements for those with muscular dystrophy.

Even more striking, in several cases, the students were able to prevent dystrophic animals from developing signs of sickness. “It was very few cases, and the illness did not go away, but the C. elegans did not show any symptoms of it in their actions,” said Vidal-Gadea. “Our next steps will be to explore what chain of events might have led to the reversal.”

The lab will continue to work with the help of NIH funding. Students involved include graduate, undergraduate, and high school students, along with collaboration with individuals at the University of Illinois and the Fred Hutch Center in Seattle, Washington. “We use a wide array of techniques that can be complicated,” said Vidal-Gadea. “The work these students are doing is propelling them in terms of research and moving toward their goals of medical school or lab experience.”


Discovery points to innovative new way to treat Duchenne muscular dystrophy


More information:
K. J. Hughes et al. Physical exertion exacerbates decline in the musculature of an animal model of Duchenne muscular dystrophy, Proceedings of the National Academy of Sciences (2019). DOI: 10.1073/pnas.1811379116


Provided by
Illinois State University

Citation:
New breakthroughs for muscular dystrophy research (2019, February 15)
retrieved 16 February 2019
from https://medicalxpress.com/news/2019-02-breakthroughs-muscular-dystrophy.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tagged with:

About author

Related Articles